Definitive Contract W81XWH16C0202
Award Date
9/29/16
Potential Completion Date
10/31/19
Potential Value
$2.7M
Federal Agency
Medical Command
Awardee
Stratatech Corporation
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AN93 - R&D- Medical: Other (Advanced Development)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53719, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services (HHS) awarded a $45,406,684.99 cost-plus-fixed-fee contract to Stratatech Corporation, a subsidiary of Mallinckrodt Plc, for the development of Stratagraft, a living cell-based tissue with characteristics similar to human skin. This contract is part of the HHS's Advanced Development of Stratagraft major program. Stratatech Corporation, a foreign-owned for-profit organization, has a history of federal grant awards for innovative regenerative...
This federal contract award, identified as W81XWH15C0080, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense (DOD) to Stratatech Corporation, a foreign-owned, for-profit company. The $999,957.14 cost-plus-fixed-fee contract was awarded on September 30, 2015 with a completion date of February 28, 2019. The contract was set aside for small businesses. Stratatech Corporation is a subsidiary of Mallinckrodt Plc and has been registered in SAM.gov since 2005 to receive...
<p>The U.S. Defense Health Agency awarded a $23,204.00 firm fixed price purchase order contract to Lifecell Corporation, a division of Allergan, Inc., for the delivery of STRATTICE - 20 X 25 products. The contract has an ultimate completion date of June 6, 2016 and was awarded on May 27, 2016. This contract award was not associated with a set-aside program.</p>
<p>The U.S. Department of the Navy's Bureau of Medicine and Surgery awarded a Firm Fixed Price purchase order contract to LifeCell Corporation, a division of Allergan, Inc., for the delivery of STRATTICE RECONSTRUCTIVE TISSUE. The contract has a ceiling value of $3,574.00 and a completion date of May 20, 2015. The contract was not set aside for any particular business type. No additional details about a larger vehicle or major subcontractors were provided.</p>
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract is a delivery order for the company's APLIGRAF product, a skin substitute used in advanced wound care. The award is part of a larger $183.15 million multiple-award Indefinite Delivery Contract (IDC) the DLA awarded to Organogenesis and other suppliers for medical and surgical supplies under the...
This federal contract award was made by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer of goods. The contract, with a ceiling value of $78,582.00, is for the procurement of 2540002-STRATTICE 25 X 40CM products. The contract type is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing structure. The place of performance is Bethesda, MD. The contract has no set-aside designation and the ultimate completion date is June 14, 2016.
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
This is a federal contract award to Geo-Med, LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB), for the delivery of Strattice Reconstructive Tissue Matrix medical supplies. The $3,573.90 fixed-price contract with economic price adjustment was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency, on February 21, 2025 with a completion date of April 8, 2025. The award is part of a larger $49,000,000 multiple-award Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
This is a delivery order awarded to Geo-Med, LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB), by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) for the procurement of Strattice Reconstructive Tissue Matrix. The contract has a ceiling value of $14,296.70 and a period of performance through March 19, 2024. Additionally, Geo-Med, LLC holds a Single Award Indefinite Delivery Contract with the Department of Veterans Affairs (VA) Veterans Health...